Shield Therapeutics's total assets for Q2 2024 were £36.99M, a decrease of -3.37% from the previous quarter. GB:STX total liabilities were £36.56M for the fiscal quarter, a 38.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.